UC, UC Health to launch Phase 3 clinical trial for COVID-19 vaccine
Vaccine uses a genetic code to produce proteins that may generate protective antibodies
Researchers at the University of Cincinnati and UC Health will host a Phase 3 clinical trial to evaluate the effectiveness of a vaccine for COVID-19, the respiratory illness caused by the novel coronavirus SARS-CoV-2.
UC is one of approximately 90 sites across the United States selected for the study, which will administer the vaccine candidate mRNA-1273 to volunteer participants and monitor its efficacy in eliciting an immune response that provides protection from COVID-19. The National Institute of Allergy and Infectious Diseases, (NIAID), part of the National Institutes of Health, is funding the study.
Carl Fichtenbaum, MD, of the UC College of Medicine Division of Infectious Diseases, medical director of the COVID-19 vaccine trial. Photo/Colleen Kelley/UC Creative + Brand
“UC was chosen because we have a proven track record of high-quality research and are the number one site in the NIAID-funded, AIDS Clinical Trials Group in the U.S. We are proud to bring leading-edge research to Cincinnati so that we can help our community battle the COVID-19 pandemic and be part of the solution,” said Carl Fichtenbaum, MD, professor in the Division of Infectious Diseases at the UC College of Medicine and a UC Health physician.
Fichtenbaum is co-investigator of the study and will serve as medical director.
Read the full story here.
Featured photo of COVID-19 vials by Colleen Kelley/UC Creative + Brand
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Stay up on all UC's COVID-19 stories, read more #UCtheGood content, or take a UC virtual visit and begin picturing yourself at an institution that inspires incredible stories.
Related Stories
Before the medals: The science behind training for freezing mountain air
February 19, 2026
From freezing temperatures to thin mountain air, University of Cincinnati exercise physiologist Christopher Kotarsky, PhD, explained how cold and altitude impact Olympic performance in a recent WLWT-TV/Ch. 5 news report.
Blood Cancer Healing Center realizes vision of comprehensive care
February 19, 2026
With the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen, the University of Cincinnati Cancer Center’s Blood Cancer Healing Center has brought its full mission to life as a comprehensive blood cancer hub.
Nursing innovation emerges as critical lever in healthcare transformation
February 18, 2026
Recognizing both the urgency and the opportunity, the University of Cincinnati (UC) College of Nursing is taking deliberate steps to position nurses at the forefront of healthcare transformation. It has created an Innovation Strategic Plan and established a dedicated Industry Advisory Board to forge the academic-industry partnerships essential to accelerating nurse-driven innovation.